4//SEC Filing
Liu Joy 4
Accession 0000899243-22-029023
CIK 0000875320other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:36 PM ET
Size
13.9 KB
Accession
0000899243-22-029023
Insider Transaction Report
Form 4
Liu Joy
SVP, General Counsel
Transactions
- Sale
Common Stock
2022-08-15$301.63/sh−698$210,538→ 12,448 total - Sale
Common Stock
2022-08-15$305.01/sh−1,743$531,632→ 9,905 total - Sale
Common Stock
2022-08-15$305.57/sh−300$91,671→ 9,605 total - Sale
Common Stock
2022-08-15$300.26/sh−206$61,854→ 13,146 total - Sale
Common Stock
2022-08-15$302.35/sh−100$30,235→ 12,348 total - Sale
Common Stock
2022-08-15$303.99/sh−700$212,793→ 11,648 total
Footnotes (7)
- [F1]Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- [F2]Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $300.26 (range $300.00 to $300.28).
- [F4]Open market sales reported on this line occurred at a weighted average price of $301.63 (range $301.23 to $302.01).
- [F5]Open market sales reported on this line occurred at a weighted average price of $303.99 (range $303.48 to $304.46).
- [F6]Open market sales reported on this line occurred at a weighted average price of $305.01 (range $304.54 to $305.53).
- [F7]Open market sales reported on this line occurred at a weighted average price of $305.57 (range $305.55 to $305.58).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001847529
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:36 PM ET
- Size
- 13.9 KB